K. A. Papp, A. Blauvelt, M. Flack, Y. Gu, and E. H. Thompson, “Clinical Responses in Patients with Moderate-to-Severe Plaque Psoriasis Following Withdrawal and Re-Treatment with Risankizumab or Switching from Ustekinumab to Risankizumab”, J of Skin, vol. 1, no. 3.1, p. s5, Oct. 2017.